Saturday, August 1, 2026

SK Group Chairman Meets OpenAI CEO Sam Altman in Seoul, Sparking AI Collaboration Buzz

SK Group Chairman Chey Tae Won met OpenAI CEO Sam Altman to discuss AI collaboration amid rising interest in generative AI technologies.

NVIDIA Surges Again! Stock Hits $123.51 as AI Hype Grows!

NVIDIA surged over 2% following a positive report from Bain & Company, reclaiming a market capitalization of $3 trillion.

Messi Leads Argentina to a 2-0 Win at Copa América

Lionel Messi, known as the God of...

Health

Enhanced Recovery Protocol Speeds Recovery After Brain Aneurysm Surgery, Study Finds

Enhanced Recovery After Surgery (ERAS) can significantly improve recovery speed for patients undergoing brain aneurysm surgery.

Celltrion’s Omlyclo Gains Traction in Italy, Reinforcing Direct Sales Strategy as Growth Expected to Accelerate

Celltrion expands its biosimilar supply in Italy, enhancing its competitiveness in the European pharmaceutical market.

CG Bio Treats First U.S. Patient With Bone Graft Substitute, Advances FDA Approval

Sigibio accelerates clinical development for FDA approval after the first U.S. patient procedure with its next-gen bone substitute, Novosis Putty.

Is Winuf IV the Future of Nutritional IV Therapy? A Deep Dive into Omega-3’s Role in Healing

JW Pharmaceutical introduces clinical applications of omega-3 based nutrient infusion Winuf Inj. to medical professionals.

Next-Gen Surface Induction Radiation Therapy: A Game Changer for Breast Cancer Patients?

Breast cancer patients may soon avoid discomfort from tattoos or markings during radiation therapy.
Latest

“Can I Have a Baby Too?” Hospital Gives Hope to Mothers With Heart Valve Disease

A study highlights successful pregnancies for women with heart valve disease, emphasizing the need for multidisciplinary care and risk assessment.

How an 82-Year-Old Defied Odds: Successful Removal of Brainstem Cancer with Keyhole Surgery

An 82-year-old's brainstem tumor was successfully removed using minimally invasive surgery, restoring his motor function and independence.

How Celltrion’s Truxima Dominates the U.S. Rituximab Market: A 4-Month Winning Streak

Celltrion's Truxima leads the U.S. rituximab market for four months, gaining FDA interchangeability status, boosting growth prospects.

Breakthrough in MASH Treatment: How miRNA-10a Outperforms Resmetirom in Fat Reduction

RXBio's miRNA-10a shows superior efficacy over Resmetirom in treating MASH, reducing fat, fibrosis, and inflammation significantly.

How Peony Root Extract Reduces Inflammation: A Breakthrough in Gut-Brain Health

A study reveals Moutan Cortex extract may reduce intestinal inflammation and improve brain function, highlighting its potential for treating anxiety.

Neurophet AQUA AD Plus: The Innovative AI Tool Designated for Public Health in 2026

Neurophet's Alzheimer's treatment solution, Neurophet AQUA AD Plus, gains innovative product status, enhancing public procurement access.

Kolon TissueGene Says TG-C Fails to Meet Statistical Significance in First Phase 3 Trial Analysis in U.S.

Kolon TissueGene's Phase 3 trial for TG-C showed pain relief but lacked statistical significance compared to placebo; further analysis underway.

“Even in Their 80s, Patients Can Walk Hand in Hand With Grandchildren”… Spine Surgery for Older Adults Has Changed

Older patients face challenges with spine surgery due to misconceptions, but advances in minimally invasive techniques offer safer options.

Samsung Biologics Accelerates “Three-Pillar Expansion Strategy” With Peptide CDMO Acquisition to Drive Global Growth

Samsung Biologics acquires Polypeptide Group for $1.8 billion, expanding into the peptide CDMO market to enhance growth and capabilities.

Same Blood Pressure, Different Risks: 24-Hour Blood Pressure Monitoring Is Changing Hypertension Management

Understanding blood pressure variability is key in hypertension care, with 24-hour monitoring revealing hidden risks beyond clinic readings.

[Interview] Excelthera Expands Portfolio With Immune Cell Culture Media, Accelerating Global Partnership Efforts

Excelthera aims to expand globally by launching new immune cell culture media and seeking global partners for collaboration.

Kangstem Biotech Signs Organoid Technology Evaluation Agreement With Global Top Five Pharmaceutical Company

Kangstem Biotech has signed an agreement with a top pharmaceutical company to evaluate drug candidates using its hair follicle organoid platform.

Managing Cancer Pain: Essential Strategies for Comfort and Recovery

Effective pain management is crucial for cancer patients, enhancing treatment outcomes and quality of life. Early intervention is key.

2026 Breakthrough in Medical Imaging: Discover How New Polymer ICG Improves Fluorescence Stability

A study improves near-infrared dye stability for tumor imaging, enhancing medical diagnostics by reducing fluorescence loss during procedures.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.